Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: The JAPAN-ACS subanalysis study

Circulation Journal

Volumn 76, Issue 12, 2012, Pages 2840-2847

  Takashima, Hiroaki ^a   Ozaki, Yukio ^b   Morimoto, Takeshi ^c   Kimura, Takeshi ^d   Hiro, Takafumi ^e   Miyauchi, Katsumi ^f   Nakagawa, Yoshihisa ^g   Yamagishi, Masakazu ^h   Daida, Hiroyuki ^f   Mizuno, Tomofumi ^a   Asai, Kenji ^a   Kuroda, Yasuo ^a   Kosaka, Takashi ^a   Kuhara, Yasushi ^a   Kurita, Akiyoshi ^a   Maeda, Kazuyuki ^a   Amano, Tetsuya ^a   Matsuzaki, Masunori ⁱ  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TENRI HOSPITAL   (Japan)

^h KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

ⁱ YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute coronary syndrome; Intravascular ultrasound; Metabolic syndrome components; Plaque; Statins

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PITAVASTATIN; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CONTROLLED STUDY; DISTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SYSTOLIC BLOOD PRESSURE;

ACUTE CORONARY SYNDROME; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; JAPAN; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; PYRROLES; QUINOLINES; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84870495078     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1495     Document Type: Article

References (32)

1. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
2. Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T, et al. Metabolic syndrome and cardiac disease in Japanese men: Applicability of the concept of metabolic syndrome defned by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men: The Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203-208.
3. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414.
4. Nakatani D, Sakata Y, Sato H, Mizuno H, Shimizu M, Suna S, et al. Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction. Am J Cardiol 2007; 99: 885-889.
5. Dohi T, Miyauchi K, Kasai T, Kajimoto K, Kubota N, Tamura H, et al. Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome. Circ J 2009; 73: 1454-1458.
6. Feinberg MS, Schwartz R, Tanne D, Fisman EZ, Hod H, Zahger D, et al. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol 2007; 99: 667-672.
7. Hulten E, Jackson JL, Douglas K, George S, Villines TC. The effect of early, intensive statin therapy on acute coronary syndrome: A meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 1814-1821.
8. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
9. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: Demonstration of the benefcial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH Study. Circulation 2004; 110: 1061-1068.
10. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: A multi-center randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 2009; 54: 293-302.
11. Bayturan O, Tuzcu EM, Lavoie A, Hu T, Wolski K, Schoenhagen P, et al. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Arch Intern Med 2010; 170: 478-484.
12. Miyauchi K, Kimura T, Morimoto T, Nakagawa Y, Yamagishi M, Ozaki Y, et al. Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): Rationale and design. Circ J 2006; 70: 1624-1628.
13. The Examination Committee of Criteria for Metabolic Syndrome. The defnition and criteria of metabolic syndrome. J Jpn Soc Intern Med 2005; 94: 794-809 (in Japanese).
14. Rohlfng CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defning the relationship between plasma glucose and HbA(1c): Analysis of glucose profles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002; 25: 275-278.
15. Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, et al. Impact of metabolic syndrome on tissue characteristics of angiograph-ically mild to moderate coronary lesions integrated backscatter intra-vascular ultrasound study. J Am Coll Cardiol 2007; 49: 1149-1156.
16. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: A new worldwide definition. Lancet 2005; 366: 1059-1062.
17. Yamashita S, Tsubakio-Yamamoto K, Ohama T, Nakagawa-Toyama Y, Nishida M. Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions. J Atheroscler Thromb 2010; 17: 436-451.
18. Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A. HDL and arteriosclerosis: Beyond reverse cholesterol transport. Atherosclerosis 2002; 161: 1-16.
19. Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Takahashi H, et al. Coronary plaque regression and lifestyle modifcation in patients treated with pravastatin: Assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipopro-tein cholesterol. Circ J 2010; 74: 954-961.
20. Ishikawa K, Tani S, Watanabe I, Matsumoto M, Furukawa K, Nomoto K, et al. Effect of pravastatin on coronary plaque volume. Am J Car-diol 2003; 92: 975-977.
21. Connor SL, Connor WE, Sexton G, Calvin L, Bacon S. The effects of age, body weight and family relationships on plasma lipoproteins and lipids in men, women and children of randomly selected families. Circulation 1982; 65: 1290-1298.
22. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, et al. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome: Serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). Circ J 2010; 74: 1165-1174.
23. Sipahi I, Tuzcu EM, Schoenhagen P, Wolski KE, Nicholls SJ, Balog C, et al. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006; 48: 833-838.
24. Takashima H, Ozaki Y, Yasukawa T, Waseda K, Asai K, Wakita Y, et al. Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque. Circ J 2007; 71: 1678-1684.
25. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006; 295: 1556-1565.
26. Irie F, Iso H, Noda H, Sairenchi T, Otaka E, Yamagishi K, et al. Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, fndings on overweight and non-overweight individuals: Ibaraki Prefectural Health Study. Circ J 2009; 73: 1635-1642.
27. Kasai T, Miyauchi K, Kajimoto K, Kubota N, Kurata T, Amano A, et al. The impact of pravastatin therapy on long-term outcome in patients with metabolic syndrome undergoing complete coronary re-vascularization. Circ J 2009; 73: 2104-2109.
28. Shiraishi J, Kohno Y, Sawada T, Nishizawa S, Arihara M, Hadase M, et al. Relation of obesity to acute myocardial infarction in Japanese patients. Circ J 2006; 70: 1525-1530.
29. Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Takahashi H, et al. Association of body mass index with coronary plaque regression: 6-month prospective study. J Atheroscler Thromb 2009; 16: 275-282.
30. von Birgelen C, Hartmann M, Mintz GS, van Houwelingen KG, Deppermann N, Schmermund A, et al. Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation 2004; 110: 1579-1585.
31. Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Yanagisawa N, Tamura H, et al. Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): A follow-up study. Atherosclerosis 2010; 210: 497-502.
32. Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Yanagisawa N, Tamura H, et al. Plaque regression determined by intravascular ultrasound predicts long-term outcomes of patients with acute coronary syndrome. J Atheroscler Thromb 2011; 18: 231-239.